臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| Total items :0
	Visitors : 52821976 Online Users : 685 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library

Scope

Adv. Search

Login

Administrator

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hsu c"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 446-455 of 881 (89 Page(s) Totally)
<< < 40 41 42 43 44 45 46 47 48 49 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2020-12-02T02:35:51Z	Quality of life of lung cancer patients: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13	Chie W.-C.;Yang C.-H.;Hsu C.;Pan-Chyr Yang; Chie W.-C.; Yang C.-H.; Hsu C.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:35:46Z	Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials	Kuo S.-H.;Yang C.-H.;Yu C.-J.;Hsu C.;Cheng A.-L.;Pan-Chyr Yang; Kuo S.-H.; Yang C.-H.; Yu C.-J.; Hsu C.; Cheng A.-L.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:35:37Z	Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status	Su W.-P.;Yang C.-H.;Yu C.-J.;Shih J.-Y.;Hsu C.;Pan-Chyr Yang; Su W.-P.; Yang C.-H.; Yu C.-J.; Shih J.-Y.; Hsu C.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:49Z	Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer	Yang C.-H.; Shih J.-Y.; Chen K.-C.; Yu C.-J.; Yang T.-Y.; Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Pan-Chyr Yang; Yang C.-H.; PAN-CHYR YANG et al.
臺大學術典藏	2020-12-02T02:34:36Z	Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment	Lin Z.-Z.; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; PAN-CHYR YANG; Yang C.-H.
臺大學術典藏	2020-12-02T02:34:30Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Hsu C.; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; PAN-CHYR YANG; Yang C.-H.
臺大學術典藏	2020-11-27T08:14:24Z	Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma	Hsiao S.-M.;Chen C.-A.;Hsu C.;Lin H.-H.;Chang-Yao Hsieh;Wei L.-H.; Hsiao S.-M.; Chen C.-A.; Hsu C.; Lin H.-H.; CHANG-YAO HSIEH; Wei L.-H.
臺大學術典藏	2020-11-19T03:43:04Z	HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity	Huang C.-L.; Hsu H.-C.; PO-HUANG LEE; Wang S.-J.; Cheng A.-L.; Hsu C.; Hsu C.;Huang C.-L.;Hsu H.-C.;Po-Huang Lee;Wang S.-J.;Cheng A.-L.
臺大學術典藏	2020-11-19T03:42:56Z	Low-dose thalidomide treatment for advanced hepatocellular carcinoma	Hsu C.;Chen C.-N.;Chen L.-T.;Wu C.-Y.;Yang P.-M.;Lai M.-Y.;Po-Huang Lee;Cheng A.-L.; Hsu C.; Chen C.-N.; Chen L.-T.; Wu C.-Y.; Yang P.-M.; Lai M.-Y.; PO-HUANG LEE; Cheng A.-L.
臺大學術典藏	2020-11-19T03:19:32Z	Lc3 over-expression improves survival and attenuates lung injury through increasing autophagosomal clearance in septic mice	Lo S.; Yuan S.-S.F.; Hsu C.; Cheng Y.-J.; Chang Y.-F.; Hsueh H.-W.; PO-HUANG LEE; Hsieh Y.-C.

Showing items 446-455 of 881 (89 Page(s) Totally)
<< < 40 41 42 43 44 45 46 47 48 49 > >>
View [10|25|50] records per page